Murillo-Zamora E, Hernández-Suárez C M
Departamento de Epidemiología, Unidad de Medicina Familiar No. 19, Instituto Mexicano del Seguro Social, Colima, Mexico.
Facultad de Ciencias, Universidad de Colima, Colima, Mexico.
Rev Clin Esp (Barc). 2021 Dec;221(10):582-586. doi: 10.1016/j.rceng.2020.09.003. Epub 2021 Mar 26.
This study aimed to evaluate the performance, before and during the COVID-19 pandemic, of the case definition of suspected influenza used in community surveillance in Mexico.
A cross-sectional analysis of a cohort study was performed and cases that met the suspected case criteria (n = 20,511) and that had laboratory-conclusive evidence (quantitative real-time polymerase chain reaction) to confirm or discard influenza virus infection were analysed.
A high sensitivity and modest specificity were documented, which later decreased during the COVID-19 outbreak, as well as its diagnostic accuracy. However, no significant differences were observed in the area under the receiver operating characteristics curve among the analysed periods.
The evaluated case definition remains to be a cost-effective alternative for identifying patients who may benefit from influenza-specific antiviral drugs, even during the global COVID-19 outbreak.
本研究旨在评估墨西哥社区监测中使用的疑似流感病例定义在新冠疫情之前及期间的表现。
对一项队列研究进行横断面分析,分析符合疑似病例标准(n = 20511)且有实验室确诊证据(定量实时聚合酶链反应)以确认或排除流感病毒感染的病例。
记录到高敏感性和适度特异性,在新冠疫情暴发期间其敏感性和诊断准确性随后下降。然而,在分析的各个时期之间,受试者工作特征曲线下面积未观察到显著差异。
即使在全球新冠疫情暴发期间,所评估的病例定义仍是识别可能从流感特异性抗病毒药物中获益患者的一种具有成本效益的替代方法。